Breadcrumb

RESP  |  Translational Research in Respiratory Diseases Program

Leadership and Management

The Translational Research in Respiratory Diseases Program (RESP) is managed by a Program Management Committee made up of the program leadership, representatives from the Centre for Translational Biology (CTB), the Centre for Outcomes Research and Evaluation (CORE) and the Centre for Innovative Medicine (CIM), external members and trainees. The committee is responsible for establishing the RESP Program’s overall goals, recruitment objectives, and training activities.
   

Simon Rousseau
Interim program co-leader

Tania Janaudis-Ferreira
Program co-Leader

Dr. Sabah Hussain
CTB Representative
   

Dr. Bruce Mazer
CTB Representative

Dr. Kevin Schwartzman
CORE Representative

Dr. Benjamin Smith
CORE Representative
   
   

Dr. Jean Bourbeau
CIM Representative

Dr. Larry Lands
CTB Representative

Dr. Deborah Assayag
CORE Representative
   

Dr. Gregory Fonseca
CTB Representative

Dr. Dao Nguyen
CTB Representative

Motahareh
Vameghestahbanati
Trainee Representative
   

Farah Al-Huda
Trainee Representative

Inga Murawski, PhD
Program Manager

Mrs. Linda Karpowicz
Program Assistant

 

 

Manager
Inga Murawski, PhD, received her doctorate in human genetics from McGill University. Her graduate studies focused on the genetic and developmental origins of pediatric kidney and urinary tract abnormalities. Following this, she joined the Institute of Cancer Research at the Canadian Institutes of Health Research (CIHR), where she helped develop the CIHR Personalized Medicine Signature Initiative, was involved in the development of strategic funding opportunities, and actively helped organize conferences, workshops, new Investigator meetings and Cafés Scientifiques.